LEXX logo

Lexaria Bioscience Corp. (LEXX)

Profile

Full Name

Lexaria Bioscience Corp.

Ticker

NASDAQ: LEXX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

January 12, 2021

Indexes

Not included

Website

https://lexariabioscience.com

Employees

7

Key Details

Price

$1.09(-2.68%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$464.30K(105.26% YoY)

Annual EPS

-$0.47(53.56% YoY)

PE Ratio

-

Next earnings date

Jan 9, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.09
    LEXX price is $1.09

    30-Day Relative Volume

    0.25
    LEXX 30-day relative volume is 0.25

    Price Performance

    Price Most Recent Change

    -2.68%
    LEXX price was down -2.68% on Nov 28, 2025

    Price YTD Change

    -48.1%
    LEXX price is down -48.1% since January 1st

    Price 1-Year Change

    -47.85%
    LEXX price is down -47.85% year-on-year

    Price 3-Year Change

    -55.33%
    LEXX price is down -55.33% over the past 3 years

    Price Range

    Price All-Time High

    $12.50
    LEXX price is currently -91.28% below its historical high of $12.50

    Price 3-Year Low

    $0.65
    LEXX price is currently +67.95% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $24.23M
    LEXX market cap is $24.23 million

    Market Cap 3-Year Change

    +66.84%
    LEXX market cap is up +66.84% over the past 3 years

    Market Cap All-Time High

    $77.42M
    LEXX market cap is currently -68.71% below its historical high of $77.42 million

    Market Cap Sector Percentile

    25.56%
    LEXX market cap is higher than 25.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +27.35%
    LEXX shares outstanding is up +27.35% year-on-year

    Shares Outstanding 3-Year Change

    +273.48%
    LEXX shares outstanding is up +273.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.86
    LEXX beta is 0.86

    200-day SMA

    $1.11
    LEXX price is currently -2.23% below its 200-day simple moving average

    50-day SMA

    $1.03
    LEXX price is currently +6.31% above its 50-day simple moving average

    14-Day RSI

    54.08
    LEXX 14-day relative strength index is 54.08

    Volume

    0.25
    LEXX 30-day relative volume is 0.25

    ATR

    $0.08
    LEXX average true range is $0.08

    10-day Historical Volatility

    58.97%
    LEXX 10-day historical volatility is 58.97%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $464.30K
    LEXX annual revenue is $464.30 thousand

    Revenue Analysts Estimate

    $669.00K
    LEXX annual revenue is currently -30.60% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +105.26%
    LEXX annual revenue is up +105.26% year-on-year

    Revenue Sector Percentile

    34.22%
    LEXX annual revenue is higher than 34.22% of companies in Healthcare sector

    EPS

    EPS

    -$0.47
    LEXX annual earnings per share is -$0.47

    EPS Analysts Estimate

    -$0.68
    LEXX annual earnings per share is currently +30.84% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +53.56%
    LEXX annual earnings per share is up +53.56% year-on-year

    EPS Sector Percentile

    68.37%
    LEXX annual earnings per share is higher than 68.37% of companies in Healthcare sector

    Profit

    Gross Profit

    $383.30K
    LEXX annual gross profit is $383.30 thousand

    Gross Margin

    82.55%
    LEXX annual gross profit margin is 82.55%

    Operating Profit

    -$5.70M
    LEXX annual operating income is -$5.70 million

    Operating Margin

    -1226.64%
    LEXX annual operating profit margin is -1226.64%

    Net Income

    -$5.81M
    LEXX annual net profit is -$5.81 million

    Net Margin

    -1251.07%
    LEXX annual net profit margin is -1251.07%

    Expenses

    Total Expenses

    $6.26M
    LEXX annual total expenses is $6.26 million

    Operating Expenses

    $6.08M
    LEXX annual total operating expenses is $6.08 million

    Cost Of Goods Sold

    $81.00K
    LEXX annual cost of goods sold is $81.00 thousand

    Selling, General & Administrative Expenses

    $3.85M
    LEXX annual SG&A is $3.85 million

    Depreciation & Amortization

    $76.20K
    LEXX annual D&A is $76.20 thousand

    Interest Expense

    $0.00
    LEXX annual interest expense is $0.00

    Income Tax

    $0.00
    LEXX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$5.70M
    LEXX annual earnings before interest & taxes is -$5.70 million

    EBITDA

    -$5.62M
    LEXX annual EBITDA is -$5.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $8.87M
    LEXX annual total assets is $8.87 million

    Non Current Assets

    $969.80K
    LEXX annual long term assets is $969.80 thousand

    Current Assets

    $7.90M
    LEXX annual total current assets is $7.90 million

    Cash and Cash Equivalents

    $6.56M
    LEXX annual cash & cash equivalents is $6.56 million

    Accounts Receivable

    -
    LEXX annual accounts receivable value is unknown

    Inventory

    $0.00
    LEXX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $1.21M
    LEXX annual total liabilities is $1.21 million

    Long Term Liabilities

    $109.30K
    LEXX annual total long term liabilities is $109.30 thousand

    Current Liabilities

    $1.10M
    LEXX annual current liabilities is $1.10 million

    Accounts Payable

    $379.90K
    LEXX annual accounts payable is $379.90 thousand

    Debt

    Total Debt

    $137.40K
    LEXX annual total debt is $137.40 thousand

    Total Debt 1-Year Change

    -16.22%
    LEXX annual total debt is down -16.22% year-on-year

    Long Term Debt

    $109.30K
    LEXX annual long term debt is $109.30 thousand

    Short Term Debt

    $28.00K
    LEXX annual short term debt is $28.00 thousand

    Equity & Capital

    Shareholders Equity

    $8.04M
    LEXX annual stockholders equity is $8.04 million

    Book Value

    $8.04M
    LEXX annual book value is $8.04 million

    Retained Earnings

    -$51.56M
    LEXX annual retained earnings is -$51.56 million

    Working Capital

    $6.80M
    LEXX annual working capital is $6.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$4.96M
    LEXX annual cash from operations is -$4.96 million

    Cash From Operations 1-Year Change

    +15.68%
    LEXX annual cash from operations is up +15.68% year-on-year

    Cash From Investing

    -$188.60K
    LEXX annual cash from investing is -$188.60 thousand

    Cash From Investing 1-Year Change

    -11.2%
    LEXX annual cash from investing is down -11.2% year-on-year

    Cash From Financing

    $10.32M
    LEXX annual cash from financing is $10.32 million

    Cash From Financing 1-Year Change

    +548.88%
    LEXX annual cash from financing is up +548.88% year-on-year

    CAPEX

    CAPEX

    $188.60K
    LEXX annual capital expenditures is $188.60 thousand

    CAPEX 1-Year Change

    +11.2%
    LEXX annual capital expenditures is up +11.2% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$5.15M
    LEXX annual free cash flow is -$5.15 million

    Free Cash Flow 1-Year Change

    +14.93%
    LEXX annual free cash flow is up +14.93% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    82.55%
    LEXX annual gross profit margin is 82.55%

    Operating Margin

    -1226.64%
    LEXX annual operating profit margin is -1226.64%

    Net Margin

    -1251.07%
    LEXX annual net profit margin is -1251.07%

    ROA & ROE

    ROA

    -97.20%
    LEXX annual return on assets is -97.20%

    ROE

    -112.36%
    LEXX annual return on equity is -112.36%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LEXX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LEXX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    4.36
    LEXX price to book ratio is 4.36

    PB Ratio Sector Percentile

    71.8%
    LEXX price to book ratio is higher than 71.8% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    39.33
    LEXX price to sales ratio is 39.33

    PS Ratio Sector Percentile

    84.54%
    LEXX price to sales ratio is higher than 84.54% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $19.75M
    LEXX enterprise value is $19.75 million

    Enterprise Value Sector Percentile

    26.51%
    LEXX enterprise value is higher than 26.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.75
    LEXX EV/EBITDA is -1.75

    EV/EBITDA Sector Percentile

    40.57%
    LEXX EV/EBITDA is higher than 40.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    7.18
    LEXX annual current ratio is 7.18

    Quick Ratio

    7.18
    LEXX annual quick ratio is 7.18

    Leverage

    Debt To Equity

    0.02
    LEXX annual debt to equity ratio is 0.02

    Interest Coverage Ratio

    -
    LEXX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    LEXX piotroski f-score is 4

    Altman Z-Score

    2.74
    LEXX altman z-score is 2.74

    Analyst ratings

    Recent major analysts updates

    Jul 29, 25 HC Wainwright & Co.
    Buy
    Jul 1, 25 HC Wainwright & Co.
    Buy
    Jan 24, 25 HC Wainwright & Co.
    Buy
    Dec 2, 24 HC Wainwright & Co.
    Buy
    Nov 25, 24 HC Wainwright & Co.
    Buy
    Jul 18, 24 HC Wainwright & Co.
    Buy
    Jul 10, 24 HC Wainwright & Co.
    Buy
    Mar 5, 24 Maxim Group
    Buy
    Jul 21, 23 Maxim Group
    Buy

    Institutional Ownership

    Screeners with LEXX included

    Growing Shares Outstanding
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Lexaria Bioscience Corp.?
    • Does Lexaria Bioscience Corp. pay dividends?
    • What sector is Lexaria Bioscience Corp. in?
    • What industry is Lexaria Bioscience Corp. in?
    • What country is Lexaria Bioscience Corp. based in?
    • When did Lexaria Bioscience Corp. go public?
    • Is Lexaria Bioscience Corp. in the S&P 500?
    • Is Lexaria Bioscience Corp. in the NASDAQ 100?
    • Is Lexaria Bioscience Corp. in the Dow Jones?
    • When was Lexaria Bioscience Corp.'s last earnings report?
    • When does Lexaria Bioscience Corp. report earnings?

    What is the ticker symbol for Lexaria Bioscience Corp.?

    The ticker symbol for Lexaria Bioscience Corp. is NASDAQ:LEXX

    Does Lexaria Bioscience Corp. pay dividends?

    No, Lexaria Bioscience Corp. does not pay dividends

    What sector is Lexaria Bioscience Corp. in?

    Lexaria Bioscience Corp. is in the Healthcare sector

    What industry is Lexaria Bioscience Corp. in?

    Lexaria Bioscience Corp. is in the Biotechnology industry

    What country is Lexaria Bioscience Corp. based in?

    Lexaria Bioscience Corp. is headquartered in Canada

    When did Lexaria Bioscience Corp. go public?

    Lexaria Bioscience Corp.'s initial public offering (IPO) was on January 12, 2021

    Is Lexaria Bioscience Corp. in the S&P 500?

    No, Lexaria Bioscience Corp. is not included in the S&P 500 index

    Is Lexaria Bioscience Corp. in the NASDAQ 100?

    No, Lexaria Bioscience Corp. is not included in the NASDAQ 100 index

    Is Lexaria Bioscience Corp. in the Dow Jones?

    No, Lexaria Bioscience Corp. is not included in the Dow Jones index

    When was Lexaria Bioscience Corp.'s last earnings report?

    Lexaria Bioscience Corp.'s most recent earnings report was on July 14, 2025

    When does Lexaria Bioscience Corp. report earnings?

    The next expected earnings date for Lexaria Bioscience Corp. is January 9, 2026
    On this page